These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35316879)

  • 1. [Stereotactic body radiation therapy for patients with lung and liver oligometastases from colorectal cancer: a phase Ⅱ trial].
    Lei JQ; Liu WY; Tang Y; Tang Y; Li N; Ren H; Yihebali C; Sun YK; Zhang W; Bi XY; Zhao JJ; Fang H; Lu NN; Zhou AP; Wang SL; Song YW; Liu YP; Chen B; Qi SN; Cai JQ; Li YX; Jin J
    Zhonghua Zhong Liu Za Zhi; 2022 Mar; 44(3):282-290. PubMed ID: 35316879
    [No Abstract]   [Full Text] [Related]  

  • 2. SBRT-SG-01: final results of a prospective multicenter study on stereotactic body radiotherapy for liver metastases.
    Rodríguez MR; Chen-Zhao X; Hernando O; Flamarique S; Fernández-Letón P; Campo M; López M; Rodríguez M; Zucca D; Martínez D; Sánchez-Saugar E; Mañeru F; Ruiz-Zorrilla JG; de Acilu PG; Valero J; Montero A; Ciérvide R; Alvarez B; García-Aranda M; Alonso R; de la Casa MA; Alonso L; Nuñez M; Martí J; Arias F
    Clin Transl Oncol; 2024 Jul; 26(7):1790-1797. PubMed ID: 38431539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recursive partitioning model-based analysis for survival of colorectal cancer patients with lung and liver oligometastases treated with stereotactic body radiation therapy.
    Franzese C; Comito T; Franceschini D; Loi M; Clerici E; Navarria P; De Rose F; Di Brina L; Mancosu P; Reggiori G; Tomatis S; Scorsetti M
    J Cancer Res Clin Oncol; 2020 May; 146(5):1227-1234. PubMed ID: 32056005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curative-intent radiotherapy in patients with oligometastatic lesions from colorectal cancer: A single-center study.
    He X; Zhang P; Li Z; Bi F; Xu F; Wang X; Shen Y; Li Q; Qiu M
    Medicine (Baltimore); 2018 Oct; 97(40):e12601. PubMed ID: 30290630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Factors and Optimal Response Interval for Stereotactic Body Radiotherapy in Patients With Lung Oligometastases or Oligoprogression From Colorectal Cancer.
    Li S; Dong D; Geng J; Zhu X; Shi C; Zhang Y; Wang H; Zhou S; Wu H; Cai Y; Li Y; Wang W
    Front Oncol; 2019; 9():1080. PubMed ID: 31681609
    [No Abstract]   [Full Text] [Related]  

  • 6. Stereotactic body radiotherapy for distant metastases to the head and neck.
    Mutsaers A; Abugharib A; Poon I; Loblaw J; Bayley A; Zhang L; Chin L; Galapin M; Erler D; Sahgal A; Higgins K; Enepekides D; Eskander A; Karam I
    Support Care Cancer; 2024 Mar; 32(4):230. PubMed ID: 38488881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single community-based institutional series of stereotactic body radiation therapy (SBRT) for treatment of liver metastases.
    Anstadt EJ; Shumway R; Colasanto J; Grew D
    J Gastrointest Oncol; 2019 Apr; 10(2):330-338. PubMed ID: 31032102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic Body Radiation Therapy (SBRT) for Liver Oligometastases: Outcomes and Safety.
    Cazic D; Marosevic G
    Acta Med Acad; 2020 Dec; 49(3):225-231. PubMed ID: 33781065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robotic stereotactic radiotherapy for liver oligometastases from colorectal cancer: a single-center experience.
    Vernaleone M; Bonomo P; Di Cataldo V; Saieva C; Masi L; Desideri I; Greto D; Francolini G; Becherini C; Livi L
    Radiol Med; 2019 Sep; 124(9):870-876. PubMed ID: 31104277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyses of local control and survival after stereotactic body radiotherapy for pulmonary oligometastases from colorectal adenocarcinoma.
    Yamamoto T; Niibe Y; Matsumoto Y; Onishi H; Aoki M; Nishikawa A; Oh RJ; Shintani T; Yahara K; Ozaki M; Manabe Y; Jingu K
    J Radiat Res; 2020 Nov; 61(6):935-944. PubMed ID: 32940330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective phase II trial on ablative stereotactic body radiation therapy (SBRT) for medically inoperable thoracic nodes metastases.
    Franceschini D; Teriaca MA; Mancosu P; Bertolini A; Lo Faro L; Spoto R; Dominici L; Badalamenti M; Bellu L; Dei D; La Fauci F; Franzese C; Scorsetti M
    Radiother Oncol; 2024 Aug; 197():110335. PubMed ID: 38772477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity.
    Franzese C; Bonu ML; Comito T; Clerici E; Loi M; Navarria P; Franceschini D; Pressiani T; Rimassa L; Scorsetti M
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2289-2297. PubMed ID: 32524292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 30 Gy single dose stereotactic body radiation therapy (SBRT): Report on outcome in a large series of patients with lung oligometastatic disease.
    Osti MF; Agolli L; Valeriani M; Reverberi C; Bracci S; Marinelli L; De Sanctis V; Cortesi E; Martelli M; De Dominicis C; Minniti G; Nicosia L
    Lung Cancer; 2018 Aug; 122():165-170. PubMed ID: 30032826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic body radiotherapy for colorectal cancer liver metastases: A systematic review.
    Petrelli F; Comito T; Barni S; Pancera G; Scorsetti M; Ghidini A;
    Radiother Oncol; 2018 Dec; 129(3):427-434. PubMed ID: 29997034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic body radiotherapy prolongs the progression-free survival and delays the change of systemic therapy regimen in patients with lung oligoprogressive metastatic colorectal cancer.
    Li S; Dong D; Geng J; Zhu X; Shi C; Zhang Y; Wang H; Zhou S; Wu H; Cai Y; Li Y; Wang W
    Asia Pac J Clin Oncol; 2022 Apr; 18(2):e64-e72. PubMed ID: 33629479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definitive results of a prospective non-randomized phase 2 study on stereotactic body radiation therapy (sbrt) for medically inoperable lung and liver oligometastases from breast cancer.
    Franceschini D; Franzese C; Comito T; Ilieva MB; Spoto R; Marzo AM; Dominici L; Massaro M; Bellu L; Badalamenti M; Mancosu P; Scorsetti M
    Radiother Oncol; 2024 Jun; 195():110240. PubMed ID: 38522597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study.
    Milano MT; Katz AW; Zhang H; Okunieff P
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):878-86. PubMed ID: 22172903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic body radiation therapy for abdominal and pelvic oligometastases: Dosimetric targets for safe and effective local control.
    Rwigema JM; King C; Wang PC; Kamrava M; Kupelian P; Steinberg ML; Lee P
    Pract Radiat Oncol; 2015; 5(3):e183-e191. PubMed ID: 25413386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
    Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
    Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic Robotic Body Radiotherapy for Patients With Unresectable Hepatic Oligorecurrence.
    Berkovic P; Gulyban A; Nguyen PV; Dechambre D; Martinive P; Jansen N; Lakosi F; Janvary L; Coucke PA
    Clin Colorectal Cancer; 2017 Dec; 16(4):349-357.e1. PubMed ID: 28462852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.